Retatrutide Shows Multiple Metabolic Benefits in Diet‐Induced Obese <scp>MASH</scp> Mouse and Hamster Models

20260 citationsJournal Articlehybrid Open Access

Authors

François Briand · Physiogenex (France)

Camille Le Cudennec · Janssen (France)

E. Grasset · Physiogenex (France)

NATALIA BREYNER · Physiogenex (France)

Claire Bigot · Physiogenex (France)

Pierre Dillard · Janssen (France)

Thierry Sulpice ·

Abstract

Retatrutide demonstrates multiple metabolic benefits in both mouse and hamster models. Our preclinical setting will help to assess the efficacy of novel therapies targeting obesity and MASH.

Topics & Keywords

Peroxisome Proliferator-Activated Receptors Regulation of Appetite and Obesity Pharmacology and Obesity Treatment

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Obesity

DOI: 10.1002/oby.70155

Field-Weighted Citation Impact: 0.00